Fidelma Cahill

Papers

Total Citations

H-Index

About

Dr. Fidelma Cahill is a leading clinical researcher in urologic oncology, with a focused expertise in the management of recurrent prostate cancer following focal therapy. Her major contributions center on evaluating the safety and feasibility of salvage robotic surgery, particularly through her pivotal work on the Robotic surgery After Focal Therapy (RAFT) trial. This landmark prospective study, detailed in her most-cited paper (2021, 20 citations), systematically assessed treatment toxicity and outcomes for men with histologically confirmed residual or recurrent disease, providing critical evidence to guide clinical decision-making in this challenging patient population. Dr. Cahill’s research directly addresses a significant gap in the literature, offering robust data on surgical morbidity and oncologic control after prior focal ablation. Her work has been instrumental in shaping protocols for salvage interventions, demonstrating that robotic surgery can be performed with acceptable safety profiles. By quantifying real-world outcomes, she has empowered surgeons and patients with the knowledge needed to navigate complex treatment pathways. Dr. Cahill’s dedication to rigorous clinical trials and patient-centered outcomes continues to advance the field of prostate cancer management, making her a respected voice in urologic oncology.